 | • レポートコード：D0804-16135 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、103ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がん治療におけるナノテクノロジーの世界市場を広く調査・分析し、今後の市場展望をまとめております。がん治療におけるナノテクノロジーの種類別市場規模（ナノ粒子、ナノロッド、ナノファイバー、グラフェン、金属有機フレームワーク、ナノバイオセンサー、ナノ流体デバイス、ナノツール）、用途別市場規模（がん検出、イメージング、ドラッグデリバリー、放射線療法、免疫療法、光線療法）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Nanosphere Inc.、Sigma-Tau Pharmaceuticals Inc.、Combimatrix Corporation、Merck & Company Inc.、GE Healthcare、Celgene Corporation、Mallinckrodt Plc、Johnson & Johnson、Pfizer, Inc. ・地域別グローバル市場分析 2015年-2020年 ・がん治療におけるナノテクノロジーの北米市場（アメリカ、カナダ、メキシコ） ・がん治療におけるナノテクノロジーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がん治療におけるナノテクノロジーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がん治療におけるナノテクノロジーの南米市場（ブラジル、アルゼンチン） ・がん治療におけるナノテクノロジーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ナノ粒子、ナノロッド、ナノファイバー、グラフェン、金属有機フレームワーク、ナノバイオセンサー、ナノ流体デバイス、ナノツール ・用途別分析：がん検出、イメージング、ドラッグデリバリー、放射線療法、免疫療法、光線療法 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Nanotechnology in Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nanotechnology in Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nanotechnology in Cancer Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nanotechnology in Cancer Treatment market has been segmented into:
Nanoparticles
Nanorods
Nanofibers
Graphene
Metal-Organic Frameworks
Nanobiosensors
Nanofluidic Devices
Nanotools
By Application, Nanotechnology in Cancer Treatment has been segmented into:
Cancer Detection
Imaging
Drug Delivery
Radiotherapy
Immunotherapy
Phototherapy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nanotechnology in Cancer Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Nanotechnology in Cancer Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nanotechnology in Cancer Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Nanotechnology in Cancer Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Nanotechnology in Cancer Treatment Market Share Analysis
Nanotechnology in Cancer Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nanotechnology in Cancer Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nanotechnology in Cancer Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Nanotechnology in Cancer Treatment are:
Abbott Laboratories
Nanosphere Inc.
Sigma-Tau Pharmaceuticals Inc.
Combimatrix Corporation
Merck & Company Inc.
GE Healthcare
Celgene Corporation
Mallinckrodt Plc
Johnson & Johnson
Pfizer, Inc.
Table of Contents
1 Nanotechnology in Cancer Treatment Market Overview
1.1 Product Overview and Scope of Nanotechnology in Cancer Treatment
1.2 Classification of Nanotechnology in Cancer Treatment by Type
1.2.1 Global Nanotechnology in Cancer Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nanotechnology in Cancer Treatment Revenue Market Share by Type in 2019
1.2.3 Nanoparticles
1.2.4 Nanorods
1.2.5 Nanofibers
1.2.6 Graphene
1.2.7 Metal-Organic Frameworks
1.2.8 Nanobiosensors
1.2.9 Nanofluidic Devices
1.2.10 Nanotools
1.3 Global Nanotechnology in Cancer Treatment Market by Application
1.3.1 Overview: Global Nanotechnology in Cancer Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer Detection
1.3.3 Imaging
1.3.4 Drug Delivery
1.3.5 Radiotherapy
1.3.6 Immunotherapy
1.3.7 Phototherapy
1.4 Global Nanotechnology in Cancer Treatment Market by Regions
1.4.1 Global Nanotechnology in Cancer Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nanotechnology in Cancer Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nanotechnology in Cancer Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nanotechnology in Cancer Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nanotechnology in Cancer Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nanotechnology in Cancer Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nanotechnology in Cancer Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Nanosphere Inc.
2.2.1 Nanosphere Inc. Details
2.2.2 Nanosphere Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Nanosphere Inc. SWOT Analysis
2.2.4 Nanosphere Inc. Product and Services
2.2.5 Nanosphere Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sigma-Tau Pharmaceuticals Inc.
2.3.1 Sigma-Tau Pharmaceuticals Inc. Details
2.3.2 Sigma-Tau Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sigma-Tau Pharmaceuticals Inc. SWOT Analysis
2.3.4 Sigma-Tau Pharmaceuticals Inc. Product and Services
2.3.5 Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Combimatrix Corporation
2.4.1 Combimatrix Corporation Details
2.4.2 Combimatrix Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Combimatrix Corporation SWOT Analysis
2.4.4 Combimatrix Corporation Product and Services
2.4.5 Combimatrix Corporation Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck & Company Inc.
2.5.1 Merck & Company Inc. Details
2.5.2 Merck & Company Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck & Company Inc. SWOT Analysis
2.5.4 Merck & Company Inc. Product and Services
2.5.5 Merck & Company Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 GE Healthcare
2.6.1 GE Healthcare Details
2.6.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GE Healthcare SWOT Analysis
2.6.4 GE Healthcare Product and Services
2.6.5 GE Healthcare Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Celgene Corporation
2.7.1 Celgene Corporation Details
2.7.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Celgene Corporation SWOT Analysis
2.7.4 Celgene Corporation Product and Services
2.7.5 Celgene Corporation Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Mallinckrodt Plc
2.8.1 Mallinckrodt Plc Details
2.8.2 Mallinckrodt Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Mallinckrodt Plc SWOT Analysis
2.8.4 Mallinckrodt Plc Product and Services
2.8.5 Mallinckrodt Plc Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer, Inc.
2.10.1 Pfizer, Inc. Details
2.10.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pfizer, Inc. SWOT Analysis
2.10.4 Pfizer, Inc. Product and Services
2.10.5 Pfizer, Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nanotechnology in Cancer Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nanotechnology in Cancer Treatment Players Market Share
3.2.2 Top 10 Nanotechnology in Cancer Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nanotechnology in Cancer Treatment Revenue and Market Share by Regions
4.2 North America Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
5 North America Nanotechnology in Cancer Treatment Revenue by Countries
5.1 North America Nanotechnology in Cancer Treatment Revenue by Countries (2015-2020)
5.2 USA Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
6 Europe Nanotechnology in Cancer Treatment Revenue by Countries
6.1 Europe Nanotechnology in Cancer Treatment Revenue by Countries (2015-2020)
6.2 Germany Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
6.4 France Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nanotechnology in Cancer Treatment Revenue by Countries
7.1 Asia-Pacific Nanotechnology in Cancer Treatment Revenue by Countries (2015-2020)
7.2 China Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
7.5 India Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
8 South America Nanotechnology in Cancer Treatment Revenue by Countries
8.1 South America Nanotechnology in Cancer Treatment Revenue by Countries (2015-2020)
8.2 Brazil Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nanotechnology in Cancer Treatment by Countries
9.1 Middle East & Africa Nanotechnology in Cancer Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nanotechnology in Cancer Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Nanotechnology in Cancer Treatment Market Forecast by Type (2019-2024)
10.3 Nanoparticles Revenue Growth Rate (2015-2025)
10.4 Nanorods Revenue Growth Rate (2015-2025)
10.5 Nanofibers Revenue Growth Rate (2015-2025)
10.6 Graphene Revenue Growth Rate (2015-2025)
10.7 Metal-Organic Frameworks Revenue Growth Rate (2015-2025)
10.8 Nanobiosensors Revenue Growth Rate (2015-2025)
10.9 Nanofluidic Devices Revenue Growth Rate (2015-2025)
10.10 Nanotools Revenue Growth Rate (2015-2025)
11 Global Nanotechnology in Cancer Treatment Market Segment by Application
11.1 Global Nanotechnology in Cancer Treatment Revenue Market Share by Application (2015-2020)
11.2 Nanotechnology in Cancer Treatment Market Forecast by Application (2019-2024)
11.3 Cancer Detection Revenue Growth (2015-2020)
11.4 Imaging Revenue Growth (2015-2020)
11.5 Drug Delivery Revenue Growth (2015-2020)
11.6 Radiotherapy Revenue Growth (2015-2020)
11.7 Immunotherapy Revenue Growth (2015-2020)
11.8 Phototherapy Revenue Growth (2015-2020)
12 Global Nanotechnology in Cancer Treatment Market Size Forecast (2021-2025)
12.1 Global Nanotechnology in Cancer Treatment Market Size Forecast (2021-2025)
12.2 Global Nanotechnology in Cancer Treatment Market Forecast by Regions (2021-2025)
12.3 North America Nanotechnology in Cancer Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Nanotechnology in Cancer Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nanotechnology in Cancer Treatment Revenue Market Forecast (2021-2025)
12.6 South America Nanotechnology in Cancer Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nanotechnology in Cancer Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Nanotechnology in Cancer Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nanotechnology in Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nanotechnology in Cancer Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nanotechnology in Cancer Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Nanotechnology in Cancer Treatment Major Business
Table 7. Abbott Laboratories Nanotechnology in Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Nanotechnology in Cancer Treatment Product and Solutions
Table 10. Abbott Laboratories Nanotechnology in Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Nanosphere Inc. Corporate Information, Location and Competitors
Table 12. Nanosphere Inc. Nanotechnology in Cancer Treatment Major Business
Table 13. Nanosphere Inc. Nanotechnology in Cancer Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Nanosphere Inc. SWOT Analysis
Table 15. Nanosphere Inc. Nanotechnology in Cancer Treatment Product and Solutions
Table 16. Nanosphere Inc. Nanotechnology in Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sigma-Tau Pharmaceuticals Inc. Corporate Information, Location and Competitors
Table 18. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Major Business
Table 19. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Sigma-Tau Pharmaceuticals Inc. SWOT Analysis
Table 21. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Product and Solutions
Table 22. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Combimatrix Corporation Corporate Information, Location and Competitors
Table 24. Combimatrix Corporation Nanotechnology in Cancer Treatment Major Business
Table 25. Combimatrix Corporation Nanotechnology in Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Combimatrix Corporation SWOT Analysis
Table 27. Combimatrix Corporation Nanotechnology in Cancer Treatment Product and Solutions
Table 28. Combimatrix Corporation Nanotechnology in Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck & Company Inc. Corporate Information, Location and Competitors
Table 30. Merck & Company Inc. Nanotechnology in Cancer Treatment Major Business
Table 31. Merck & Company Inc. Nanotechnology in Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Merck & Company Inc. SWOT Analysis
Table 33. Merck & Company Inc. Nanotechnology in Cancer Treatment Product and Solutions
Table 34. Merck & Company Inc. Nanotechnology in Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GE Healthcare Corporate Information, Location and Competitors
Table 36. GE Healthcare Nanotechnology in Cancer Treatment Major Business
Table 37. GE Healthcare Nanotechnology in Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 38. GE Healthcare SWOT Analysis
Table 39. GE Healthcare Nanotechnology in Cancer Treatment Product and Solutions
Table 40. GE Healthcare Nanotechnology in Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Celgene Corporation Corporate Information, Location and Competitors
Table 42. Celgene Corporation Nanotechnology in Cancer Treatment Major Business
Table 43. Celgene Corporation Nanotechnology in Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Celgene Corporation SWOT Analysis
Table 45. Celgene Corporation Nanotechnology in Cancer Treatment Product and Solutions
Table 46. Celgene Corporation Nanotechnology in Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Mallinckrodt Plc Corporate Information, Location and Competitors
Table 48. Mallinckrodt Plc Nanotechnology in Cancer Treatment Major Business
Table 49. Mallinckrodt Plc Nanotechnology in Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Mallinckrodt Plc SWOT Analysis
Table 51. Mallinckrodt Plc Nanotechnology in Cancer Treatment Product and Solutions
Table 52. Mallinckrodt Plc Nanotechnology in Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Johnson & Johnson Corporate Information, Location and Competitors
Table 54. Johnson & Johnson Nanotechnology in Cancer Treatment Major Business
Table 55. Johnson & Johnson Nanotechnology in Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Johnson & Johnson SWOT Analysis
Table 57. Johnson & Johnson Nanotechnology in Cancer Treatment Product and Solutions
Table 58. Johnson & Johnson Nanotechnology in Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Pfizer, Inc. Corporate Information, Location and Competitors
Table 60. Pfizer, Inc. Nanotechnology in Cancer Treatment Major Business
Table 61. Pfizer, Inc. Nanotechnology in Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Pfizer, Inc. SWOT Analysis
Table 63. Pfizer, Inc. Nanotechnology in Cancer Treatment Product and Solutions
Table 64. Pfizer, Inc. Nanotechnology in Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Nanotechnology in Cancer Treatment Revenue (Million USD) by Players (2015-2020)
Table 66. Global Nanotechnology in Cancer Treatment Revenue Share by Players (2015-2020)
Table 67. Global Nanotechnology in Cancer Treatment Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Nanotechnology in Cancer Treatment Revenue Market Share by Regions (2015-2020)
Table 69. North America Nanotechnology in Cancer Treatment Revenue by Countries (2015-2020)
Table 70. North America Nanotechnology in Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 71. Europe Nanotechnology in Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Nanotechnology in Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Nanotechnology in Cancer Treatment Revenue by Countries (2015-2020)
Table 74. South America Nanotechnology in Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Nanotechnology in Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Nanotechnology in Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 77. Global Nanotechnology in Cancer Treatment Revenue (Million USD) by Type (2015-2020)
Table 78. Global Nanotechnology in Cancer Treatment Revenue Share by Type (2015-2020)
Table 79. Global Nanotechnology in Cancer Treatment Revenue Forecast by Type (2021-2025)
Table 80. Global Nanotechnology in Cancer Treatment Revenue by Application (2015-2020)
Table 81. Global Nanotechnology in Cancer Treatment Revenue Share by Application (2015-2020)
Table 82. Global Nanotechnology in Cancer Treatment Revenue Forecast by Application (2021-2025)
Table 83. Global Nanotechnology in Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nanotechnology in Cancer Treatment Picture
Figure 2. Global Nanotechnology in Cancer Treatment Revenue Market Share by Type in 2019
Figure 3. Nanoparticles Picture
Figure 4. Nanorods Picture
Figure 5. Nanofibers Picture
Figure 6. Graphene Picture
Figure 7. Metal-Organic Frameworks Picture
Figure 8. Nanobiosensors Picture
Figure 9. Nanofluidic Devices Picture
Figure 10. Nanotools Picture
Figure 11. Nanotechnology in Cancer Treatment Revenue Market Share by Application in 2019
Figure 12. Cancer Detection Picture
Figure 13. Imaging Picture
Figure 14. Drug Delivery Picture
Figure 15. Radiotherapy Picture
Figure 16. Immunotherapy Picture
Figure 17. Phototherapy Picture
Figure 18. Global Nanotechnology in Cancer Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. North America Nanotechnology in Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Europe Nanotechnology in Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Asia-Pacific Nanotechnology in Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. South America Nanotechnology in Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Middle East and Africa Nanotechnology in Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global Nanotechnology in Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Global Nanotechnology in Cancer Treatment Revenue Share by Players in 2019
Figure 26. Global Top 5 Players Nanotechnology in Cancer Treatment Revenue Market Share in 2019
Figure 27. Global Top 10 Players Nanotechnology in Cancer Treatment Revenue Market Share in 2019
Figure 28. Key Players Market Share Trend
Figure 29. Global Nanotechnology in Cancer Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 30. Global Nanotechnology in Cancer Treatment Revenue Market Share by Regions (2015-2020)
Figure 31. Global Nanotechnology in Cancer Treatment Revenue Market Share by Regions in 2018
Figure 32. North America Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Asia-Pacific Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 35. South America Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Middle East and Africa Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 37. North America Nanotechnology in Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 38. North America Nanotechnology in Cancer Treatment Revenue Market Share by Countries in 2019
Figure 39. USA Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Canada Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Mexico Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Europe Nanotechnology in Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Europe Nanotechnology in Cancer Treatment Revenue Market Share by Countries in 2019
Figure 44. Germany Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 45. UK Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 46. France Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Russia Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Italy Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Asia-Pacific Nanotechnology in Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. Asia-Pacific Nanotechnology in Cancer Treatment Revenue Market Share by Countries in 2019
Figure 51. China Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Japan Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Korea Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 54. India Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Southeast Asia Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South America Nanotechnology in Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 57. South America Nanotechnology in Cancer Treatment Revenue Market Share by Countries in 2019
Figure 58. Brazil Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Argentina Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Middle East and Africa Nanotechnology in Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 61. Middle East and Africa Nanotechnology in Cancer Treatment Revenue Market Share by Countries in 2019
Figure 62. Saudi Arabia Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 63. UAE Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 64. Egypt Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 65. South Africa Nanotechnology in Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 66. Global Nanotechnology in Cancer Treatment Revenue Share by Type (2015-2020)
Figure 67. Global Nanotechnology in Cancer Treatment Revenue Share by Type in 2019
Figure 68. Global Nanotechnology in Cancer Treatment Market Share Forecast by Type (2021-2025)
Figure 69. Global Nanoparticles Revenue Growth Rate (2015-2020)
Figure 70. Global Nanorods Revenue Growth Rate (2015-2020)
Figure 71. Global Nanofibers Revenue Growth Rate (2015-2020)
Figure 72. Global Graphene Revenue Growth Rate (2015-2020)
Figure 73. Global Metal-Organic Frameworks Revenue Growth Rate (2015-2020)
Figure 74. Global Nanobiosensors Revenue Growth Rate (2015-2020)
Figure 75. Global Nanofluidic Devices Revenue Growth Rate (2015-2020)
Figure 76. Global Nanotools Revenue Growth Rate (2015-2020)
Figure 77. Global Nanotechnology in Cancer Treatment Revenue Share by Application (2015-2020)
Figure 78. Global Nanotechnology in Cancer Treatment Revenue Share by Application in 2019
Figure 79. Global Nanotechnology in Cancer Treatment Market Share Forecast by Application (2021-2025)
Figure 80. Global Cancer Detection Revenue Growth Rate (2015-2020)
Figure 81. Global Imaging Revenue Growth Rate (2015-2020)
Figure 82. Global Drug Delivery Revenue Growth Rate (2015-2020)
Figure 83. Global Radiotherapy Revenue Growth Rate (2015-2020)
Figure 84. Global Immunotherapy Revenue Growth Rate (2015-2020)
Figure 85. Global Phototherapy Revenue Growth Rate (2015-2020)
Figure 86. Global Nanotechnology in Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 87. Global Nanotechnology in Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 88. Global Nanotechnology in Cancer Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 89. North America Nanotechnology in Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 90. Europe Nanotechnology in Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 91. Asia-Pacific Nanotechnology in Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 92. South America Nanotechnology in Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 93. Middle East and Africa Nanotechnology in Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
精巣腫瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Testicular Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Testicular Cancer…- 転移性大腸がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metast…
- 転移性乳がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Breast Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastatic…
- 乳腺腫瘍摘出術治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Breast Lumpectomy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- がん幹細胞（CSC）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Stem Cells (CSCs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Stem Cells (C…